Singular has led a EUR30 million Series A fuding round in Formel Skin, a healthtech startup. The funding will be used to expand the healthcare platform to new markets and launch additional medical treatments, as part of its mission to offer individualised, high-quality medical treatments online.
Other investors in the round include the HealthTech fund Heal Capital and existing investors Cherry Ventures, Heartcore Capital and Vorwerk Ventures. Since being founded in December 2019 Formel Skin has raised more than EUR36 million and is now one of the fastest-growing European HealthTech companies, having grown seven-times year-on-year since launch.
